View in EDS

The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor.

Saved in:
Bibliographic Details
Title: The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor.
Authors: Goldberg FW; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Finlay MRV; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Ting AKT; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Beattie D; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Lamont GM; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Fallan C; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Wrigley GL; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Schimpl M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Howard MR; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Williamson B; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Vazquez-Chantada M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Barratt DG; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Davies BR; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Cadogan EB; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Ramos-Montoya A; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K., Dean E; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
Source: Journal of medicinal chemistry [J Med Chem] 2020 Apr 09; Vol. 63 (7), pp. 3461-3471. Date of Electronic Publication: 2020 Jan 15.
Publication Type: News
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31851518
AccessLevel: 2
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goldberg+FW%22">Goldberg FW</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Finlay+MRV%22">Finlay MRV</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Ting+AKT%22">Ting AKT</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Beattie+D%22">Beattie D</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Lamont+GM%22">Lamont GM</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Fallan+C%22">Fallan C</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Wrigley+GL%22">Wrigley GL</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Schimpl+M%22">Schimpl M</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Howard+MR%22">Howard MR</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Williamson+B%22">Williamson B</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Vazquez-Chantada+M%22">Vazquez-Chantada M</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Barratt+DG%22">Barratt DG</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Davies+BR%22">Davies BR</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Cadogan+EB%22">Cadogan EB</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Ramos-Montoya+A%22">Ramos-Montoya A</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.<br /><searchLink fieldCode="AU" term="%22Dean+E%22">Dean E</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0FZ, U.K.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2020 Apr 09; Vol. 63 (7), pp. 3461-3471. <i>Date of Electronic Publication: </i>2020 Jan 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: News
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31851518
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.jmedchem.9b01684
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3461
    Titles:
      – TitleFull: The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goldberg FW
      – PersonEntity:
          Name:
            NameFull: Finlay MRV
      – PersonEntity:
          Name:
            NameFull: Ting AKT
      – PersonEntity:
          Name:
            NameFull: Beattie D
      – PersonEntity:
          Name:
            NameFull: Lamont GM
      – PersonEntity:
          Name:
            NameFull: Fallan C
      – PersonEntity:
          Name:
            NameFull: Wrigley GL
      – PersonEntity:
          Name:
            NameFull: Schimpl M
      – PersonEntity:
          Name:
            NameFull: Howard MR
      – PersonEntity:
          Name:
            NameFull: Williamson B
      – PersonEntity:
          Name:
            NameFull: Vazquez-Chantada M
      – PersonEntity:
          Name:
            NameFull: Barratt DG
      – PersonEntity:
          Name:
            NameFull: Davies BR
      – PersonEntity:
          Name:
            NameFull: Cadogan EB
      – PersonEntity:
          Name:
            NameFull: Ramos-Montoya A
      – PersonEntity:
          Name:
            NameFull: Dean E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 04
              Text: 2020 Apr 09
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1520-4804
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of medicinal chemistry
              Type: main
ResultId 1